Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Kimberly-Clark weighs sale of European tissues business: sources

Published 07/19/2018, 03:13 PM
Updated 07/19/2018, 03:20 PM
© Reuters. FILE PHOTO - A woman walks outside a Kimberly-Clark building in Maracay

© Reuters. FILE PHOTO - A woman walks outside a Kimberly-Clark building in Maracay

By Harry Brumpton and Martinne Geller

(Reuters) - Kimberly-Clark Corp (N:KMB) is exploring a sale of its European tissue business, as it tries to slash costs and combat slowing sales by exiting less profitable areas, according to people familiar with the matter.

The maker of Kleenex tissues and Huggies diapers has contacted private equity firms to gauge their interest in acquiring the business, which is likely to fetch above 1 billion euros ($1.2 billion), the sources said.

Kimberly-Clark's European portfolio includes toilet paper brands Andrex in Britain and Ireland, Hakle in Austria and Switzerland and Scottex in Belgium, Italy and Spain.

It was not immediately clear whether any potential divestment would also include the European licenses for brands sold both in Europe and elsewhere, such as Kleenex and Cottonelle, though the standard practice would be to include them, three of the sources said.

The sources cautioned that no deal is certain and asked not to be identified because the matter is confidential. Kimberly-Clark declined to comment.

Kimberly-Clark is one of many packaged goods companies grappling with a fast-changing landscape being rocked by the rise of e-commerce, challenger brands and changing habits.

Earlier this year, the company said it would consider exiting some lower-margin businesses, chiefly in the competitive consumer tissue segment, which is battling higher commodity costs and private label manufacturers.

The Irving, Texas-based company also said it planned to close or sell 10 of its 91 factories worldwide and cut 5,000 jobs - about 13 percent of its workforce - as it strives for more than $2 billion in cost cuts by 2021.

This would not be the company's first retreat from Europe. In 2012, it quit the diaper business in most of Western and Central Europe to focus on what it saw at the time as faster-growing regions such as China, Brazil and Russia.

In Western Europe, the retail tissue market - which includes tissues, toilet paper, napkins and paper towels - was worth about $14.7 billion last year, according to Euromonitor International. It ranks Kimberly-Clark second, with a 10 percent market share, behind Sweden's Essity (ST:ESSITYa).

© Reuters. FILE PHOTO - A woman walks outside a Kimberly-Clark building in Maracay

Europe has been tough for Kimberly-Clark, as it vies for shopper loyalty against other multinationals with deeper European focuses such as Procter & Gamble (N:PG) and Unilever (L:ULVR).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.